卒中T淋巴细胞亚群动态变化及其与卒中相关感染的关系

doi:10.3969/j.issn.1673-5765.2017.05.003

摘要/Abstract

摘要：

目的观察卒中急性期患者外周血中C D 3 +T细胞、C D 3 + C D 4 +T细胞、C D 3 + C D 8 +T细胞及 CD4+CD25+FoxP3+调节性T细胞（regulatory T cells，Tregs）的动态变化，探讨卒中后机体免疫状态及其对卒中后感染的影响。方法选取卒中急性期患者32例为卒中组，根据发病1周内是否发生感染，将患者分为卒中后非感染组24例和卒中后感染组8例。另选取性别、年龄匹配的健康体检者23例为对照组。采用流式细胞术分别于病程24 h内、3 d、7 d检测卒中患者和健康体检者外周血中CD3+T细胞、CD3+CD4+T细胞、 CD3+CD8+T细胞及Tregs水平。结果 ① 与对照组比较，卒中后非感染组CD3+CD4+T细胞与Tregs于发病后7 d升高（P分别为0.02和 0.03）；CD3+CD8+T细胞在发病后24 h及3 d下降（P分别为0.01和0.03），发病后7 d升至与健康对照组无显著差异。卒中后感染组CD3+T细胞、CD3+CD4+T细胞、CD3+CD8+T细胞及Tregs在发病24 h内（P分别为＜0.001，＜0.001，0.03和＜0.001）、3 d（P均＜0.001）、7 d（P分别为＜0.001，0.01，0.01和0.01）均较健康对照组明显下降；②卒中后感染组CD3+T细胞、CD3+CD4+T细胞及Tregs在发病后24 h内（P分别为0.01，＜0.001和＜0.001）、3 d（P分别＜0.001，＜0.001和0.04）、7 d（P均＜0.001）均显著低于卒中后非感染组；两组CD3+CD8+T细胞在发病后24 h内无明显差异，但3 d（P＜0.001）、7 d（P =0.02）卒中后感染组显著低于卒中后非感染组。结论 C D3+T淋巴细胞、CD3+CD4+T淋巴细胞、CD3+CD8+T淋巴细胞及Tregs参与卒中早期病理生理过程，其动态变化可能导致卒中后免疫抑制，并参与卒中后感染的发生。

文章导读： 本研究对比了卒中急性期患者在发生感染及无感染两种情况下与健康人群外周血T淋巴细胞亚群的差异，显示了T淋巴细胞亚群的绝对值在卒中急性期及卒中后感染过程中呈动态变化过程。

关键词: 卒中; T淋巴细胞亚群; 调节性T细胞; 免疫抑制; 感染

Abstract:

Objective To observe the dynamic changes of CD3+T cells, CD3+CD4+T cells, CD3+CD8+T cells and CD4+CD25+FoxP3+ regulatory T cells (Tregs) in peripheral blood of patients with acute stroke, and explore the immune state and its influence on infection after stroke. Methods There were 32 acute stroke patients in stroke group, and 23 age- and gender-matched healthy ones in control group. According to infection occurring within 1 week after stroke or not, 32 stroke patients were divided into infection group (n =8) and non-infection group (n =24). The levels of CD3+T cells, CD3+CD4+T cells, CD3+CD8+T cells and Tregs were determined serially on day 1, 3 and 7 after stroke onset in 32 stroke patients and 23 controls. Results ①Comparing with the control group, CD3+CD4+T cells and Tregs increased on day 7 after onset (P =0.02 and 0.03, respectively), CD3+CD8+T cells decreased on day 1 and 3 after onset (P =0.01 and 0.03, respectively) and restored to a normal level on day 7 in non-infection group. A significant

fall of CD3+T cells, CD3+CD4+T cells, CD3+CD8+T cells and Tregs were observed on day 1 (P <0.001, <0.001, 0.03 and <0.001, respectively), 3 (P <0.001), and 7 (P <0.001, 0.01, 0.01 and 0.01, respectively) after onset in infection group. ②Comparing with non-infection group, CD3+T cells, CD3+CD4+T cells, and Tregs were all significantly lower on day 1 (P =0.01, <0.001 and <0.001, respectively), 3 (P <0.001, <0.001 and 0.04, respectively) and 7 (P <0.001) after onset in infection group. There was no significant difference in CD3+CD8+T cells between the two stroke groups on day 1, while this type of T cells in infection group significantly decreased on day 3 (P <0.001) and 7 (P =0.02) after onset than that of in non-infection group. Conclusion CD3+T cells, CD3+CD4+T cells, CD3+CD8+T cells and Tregs may involve in pathophysiological process in the acute phase of stroke. The dynamic changes of T lymphocytes may induce to immunodepression, and involve in infection after stroke.

Key words: Stroke; T lymphocyte subsets; Regulatory T cells; Immunodepression; Infection

赵博，杨彬彬，王佳伟. 卒中T淋巴细胞亚群动态变化及其与卒中相关感染的关系[J]. 中国卒中杂志, 2017, 12(05): 390-395.

ZHAO Bo, YANG Bin-Bin, WANG Jia-Wei. The Dynamic Changes of T Lymphocyte Subsets in Peripheral Blood in Patients with Stroke and Their Influence on Infection after Stroke[J]. Chinese Journal of Stroke, 2017, 12(05): 390-395.

参考文献

1 Vargas M，Horcajada JP，Obach V，et al. Clinical

consequences of infection in patients with acute stroke：

is it prime time for further antibiotic trials?[J]. Stroke，

2006，37：461-465.

2 Westendorp WF，Nederkoorn PJ，Vermeij JD，et al.

Post-stroke infection：a systematic review and metaanalysis[

J]. BMC Neurol，2011，11：110.

3 Langhome P，Stott DJ，Robertson L，et a1. Medieal

complications after stroke：a multicenter study[J].

Stroke，2000，31：1223-1229.

4 Meisel C，Prass K，Braun J，Victorov I，et al.

Preventive antibacterial treatment improves the

general medical and neurological outcome in a mouse

model of stroke[J]. Stroke，2004，35：2-6.

5 Famakin BM. The Immune Response to Acute

Focal Cerebral Ischemia and Associated Post-stroke

Immunodepression：A Focused Review[J]. Aging Dis，

2014，5：307-326.

6 Hurn PD，Subramanian S，Parker SM，et al. T- and

B-cell-deficient mice with experimental stroke have

reduced lesion size and inflammation[J]. J Cereb

Blood Flow Metab，2007，27：1798-1805.

7 Kleinschnitz C，Schwab N，Kraft P，et al. Early

detrimental T-cell effects in experimental cerebral

ischemia are neither related to adaptive immunity nor

thrombus formation[J]. Blood，2010，115：3835-3842.

8 Chen S，Wu H，Klebe D，et al. Regulatory T cell in

stroke：a new paradigm for immune regulation[J].

Clin Dev Immunol，2013：689 827.

9 Liesz A，Suri-Payer E，Veltkamp C，et al. Regulatory

T cells are key cerebroprotective immunomodulators

in acute experimental stroke[J]. Nat Med，2009，15：

192-199.

10 Jauch EC，Saver JL，Adams HP Jr，et al. Guidelines

for the early management of patients with acute

ischemic stroke：a guideline for healthcare

professionals from the American Heart Association/

American Stroke Association[J]. Stroke，2013，44：

870-947.

11 Morgenstern LB，Hemphill JC，Anderson C，et

al. Guidelines for the management of spontaneous

intracerebral hemorrhage：a guideline for healthcare

professionals from the American Heart Association/

American Stroke Association[J]. Stroke，2010，41：

2108-2129.

12 American Thoracic Society; Infectious Diseases

Society of America. Guidelines for the management

of adults with hospital-acquired，ventilator-associated，

and healthcare-associated pneumonia[J]. Am J Respir

Crit Care Med，2005，171：388-416.

13 European Association of Urology 2014. Guidelines

on Urological Infections[EB/OL](2016-10-11). http：

//www.uroweb.org/gls/pdf/19%20Urological%20

infections_LR.pdf.

14 Gill D，Veltkamp R. Dynamics of T cell responses after

stroke[J]. Curr Opin Pharmacol，2016，26：26-32.

15 Liesz A，Dalpke A，Mracsko E，et al. DAMP

signaling is a key pathway inducing immune

modulation after brain injury[J]. J Neurosci，2015，35：

583-598.

16 Vogelgesang A，Grunwald U，Langner S，et al.

Analysis of lymphocyte subsets in patients with stroke

and their influence on infection after stroke[J]. Stroke，

2008，39：237-241.

17 Urra X，Cervera A，Villamor N，et al. Harms and

benefits of lymphocyte subpopulations in patients

with acute stroke[J]. Neuroscience，2009，158：1174-

1183.

18 刘秋红，张杰文，杨景瑞. 老年卒中相关性肺炎患者

外周血T淋巴细胞亚群及血清炎症因子变化的临床分

析[J]. 中国实用神经疾病杂志，2016，8：34-35.

19 Shim R. Ischemia，Immunosuppression and

Infection--Tackling the Predicaments of Post-Stroke

Complications[J]. Int J Mol Sci，2016，17.

20 赵晟珣，王桦，杨帆，等. 高龄老年肺部感染患者免疫

功能变化与免疫调节治疗临床研究[J]. 中华临床医师

杂志(电子版)，2014，6：1026-1030.

[1]	鲁燕, 杨保荣, 黄向萍, 杨冠桂, 陈圣文, 李建荣, 曾小明. 县级医院急性缺血性卒中超时间窗经MRI筛选溶栓的病例对照研究 [J]. 中国卒中杂志, 2022, 17(12): 1321-1326.
[2]	楚悦琪, 周凯云, 王田燕, 王炯彬, 李真. 卒中后吞咽障碍应用耳穴压豆治疗效果的meta分析 [J]. 中国卒中杂志, 2022, 17(12): 1327-1334.
[3]	周甜甜, 苏文杰, 连松勇, 林友聪. 丰富环境对卒中后血管性痴呆患者认知功能的影响 [J]. 中国卒中杂志, 2022, 17(12): 1343-1349.
[4]	吴娱倩, 张玉梅, 范小伟, 王安心, 逄文斌. 运动想象-动觉治疗对缺血性卒中患者手功能康复效果的研究[J]. 中国卒中杂志, 2022, 17(12): 1366-1371.
[5]	蒋林, 李靖. 基于知识图谱分析人工智能用于卒中研究的现状及趋势 [J]. 中国卒中杂志, 2022, 17(12): 1372-1380.
[6]	梁潇, 钱海兵. 水通道蛋白4与卒中后认知障碍的关系研究进展[J]. 中国卒中杂志, 2022, 17(12): 1385-1390.
[7]	吴晓莉, 刘丽旭. 肥胖对卒中预后的影响[J]. 中国卒中杂志, 2022, 17(12): 1391-1395.
[8]	伊珞, 周宏宇, 仇鑫, 李子孝, 王拥军. 动脉粥样硬化性疾病的DNA甲基化改变[J]. 中国卒中杂志, 2022, 17(11): 1163-1170.
[9]	王誉博, 李子孝, 王拥军. 表观遗传学与缺血性卒中后氧化应激的相关性研究进展[J]. 中国卒中杂志, 2022, 17(11): 1171-1177.
[10]	闫然, 闵妍, 全柯华, 李子孝. 脑源性神经营养因子和血清素再摄取转运体编码基因甲基化与卒中预后的关系[J]. 中国卒中杂志, 2022, 17(11): 1178-1182.
[11]	崔凌云, 仇鑫, 周宏宇, 李子孝, 王拥军. DNA甲基化与2型糖尿病的相关性研究进展[J]. 中国卒中杂志, 2022, 17(11): 1183-1188.
[12]	邓宇含, 刘爽, 王子尧, 汪雨欣, 刘宝花. 基于结构化数据和机器学习模型预测普通人群卒中发病风险的系统评价和meta分析 [J]. 中国卒中杂志, 2022, 17(11): 1189-1197.
[13]	刘光亮, 韩凯月, 苏文龙, 张皓. 不同强度有氧踏车训练对不同病程缺血性卒中患者运动和心肺适能的影响 [J]. 中国卒中杂志, 2022, 17(11): 1203-1208.
[14]	孙默一, 张玉梅, 刘然, 赵依双. 不同时间康复介入对卒中患者运动功能的影响 [J]. 中国卒中杂志, 2022, 17(11): 1209-1215.
[15]	胡红梅, 杨磊, 于玲, 秦伟, 白明悦, 胡文立. 急性单发小脑小梗死的临床特征 [J]. 中国卒中杂志, 2022, 17(11): 1221-1226.